Meta has spent the past several years steadily tightening what healthcare advertisers can do on its platforms. The agencies that built their playbooks before the restrictions are running campaigns that no longer work the way they think they do.
Meta — the parent company of Facebook and Instagram — is one of the most important advertising platforms for medical practices, particularly for med spas, aesthetic services, and any specialty that benefits from visual demonstration. It is also the platform with the most restrictive and most actively enforced policies for healthcare advertisers. Practices and agencies running Meta campaigns on assumptions from three or four years ago are working with a playbook that no longer applies.
Understanding the current restrictions is not just about compliance. It is about knowing which campaigns can actually be optimized properly, which targeting strategies will be allowed to run, and which approaches will be quietly throttled by the platform without explicit notification.
The Special Ad Category Designation
The most consequential restriction is the Special Ad Category. Meta designates advertising in certain categories — including credit, employment, housing, social issues, and a category that affects portions of healthcare advertising — as requiring restricted targeting.
What this means practically is that ads designated as falling under a Special Ad Category cannot use certain targeting options that are available for general advertisers. Detailed targeting based on demographic, interest, and behavioral data is limited. Lookalike audiences cannot be built in the standard way. Location targeting is restricted to a minimum radius. Age and gender targeting is restricted.
Healthcare advertising is not blanket-designated as Special Ad Category, but specific types of health-related advertising are. The designation is partly automatic, based on signals Meta detects in the ad creative and copy, and partly contextual. Practices and agencies that have run the same campaigns for years sometimes find that a campaign that was previously running normally has been quietly reclassified, with the targeting silently restricted.
Checking the current designation status of campaigns periodically is one of the audit disciplines that working healthcare advertisers maintain. Campaigns running under unexpected Special Ad Category designations rarely perform as expected, and the cause is often invisible from the campaign-level metrics alone.
What You Cannot Target
Several categories of targeting that work in general advertising are restricted or unavailable for healthcare contexts.
Health condition interests have been progressively restricted. The detailed interest categories that used to allow targeting based on inferred interest in specific conditions or treatments have been largely removed or narrowed to the point of impracticality. Targeting users because Meta’s algorithms have inferred they may be interested in a specific health condition is generally no longer an available option.
Custom audiences built from patient lists raise the same considerations addressed in Cluster 2 — uploading patient identifiers to a platform that does not sign Business Associate Agreements is structurally problematic, regardless of how Meta’s own policies treat the upload mechanically.
Demographic targeting based on age and gender is available but increasingly scrutinized for healthcare contexts. Ads that exclude specific demographics from healthcare information may run afoul of both platform policy and broader anti-discrimination considerations.
Lookalike audiences based on patient lists carry the same compliance problems as the underlying lists. Lookalikes based on website visitors are mechanically available but should be evaluated against the same data-flow considerations that apply to tracking pixels on healthcare sites.
What You Can Target Effectively
Within the restrictions, several targeting approaches remain effective and defensible.
Geographic targeting, within the minimum-radius rules for Special Ad Category designations where applicable, continues to work. For local healthcare practices, geographic targeting is often the most reliable single layer of audience definition.
Broad demographic targeting — age and gender at coarse levels appropriate to the service — remains available for most healthcare advertising. A med spa marketing services typically purchased by adults aged 30 to 60 can target that range, with the caveat that overly narrow demographic exclusions invite policy scrutiny.
Behavioral signals based on platform engagement — engagement with the practice’s own page, interactions with the practice’s content, video view audiences from the practice’s own videos — are available and effective. Building audiences from first-party engagement, rather than from health-inferred interests, is the most durable targeting approach in the current environment.
Saved audiences combining geographic, broad demographic, and first-party engagement signals tend to perform well and remain stable across policy updates.
Creative Restrictions Worth Understanding
The creative itself is subject to policies that have tightened alongside the targeting restrictions.
Before-and-after imagery is restricted in ways that catch many med spa and aesthetic advertisers off guard. Ads that show “before” and “after” states in ways that imply specific outcomes are frequently disapproved, and accounts that repeatedly submit such ads can face broader penalties.
Imagery focused on body parts — particularly close-ups that emphasize the area of treatment — is scrutinized. Aesthetic advertising in particular sits close to the line of what Meta considers acceptable, and the line has moved tighter over time.
Claims of specific outcomes — “lose 20 pounds,” “look 10 years younger,” “guaranteed results” — trigger both platform disapproval and broader advertising rule scrutiny. Ad copy should describe services and benefits in ways that are accurate without making specific outcome promises.
Imagery that emphasizes negative emotions about the viewer’s current state — addressing perceived flaws, body shame, or insecurities — is increasingly disapproved. Meta’s stated policy is that such advertising can be harmful, and enforcement has expanded over the past several years.
Account-Level Risk
Repeated policy violations have consequences beyond the individual ad. Meta tracks account-level compliance, and accounts with a history of disapprovals face increasing scrutiny on subsequent submissions, slower approval times, and ultimately the risk of restrictions on the account itself.
For agencies managing multiple healthcare accounts under a single Business Manager, this creates a structural consideration. A single ad approach that triggers repeated disapprovals across multiple clients can affect the standing of the entire Business Manager. Healthcare agencies typically separate higher-risk creative testing into specific accounts or take extra care with creative approval workflows.
Recovery from account-level restrictions is possible but slow, and prevention is meaningfully cheaper than remediation.
Where Meta Still Works for Healthcare
Despite the restrictions, Meta remains effective for several specific healthcare use cases.
Brand awareness for practices establishing themselves in a market continues to perform well, particularly with broad geographic and demographic targeting. The platform’s reach and frequency capabilities are difficult to match elsewhere.
Educational content marketing — videos and posts that demonstrate clinical expertise, explain procedures, or address common patient questions — continues to work as both organic and paid content. The targeting restrictions affect direct response campaigns more than awareness campaigns.
Retargeting based on first-party website engagement, configured with appropriate compliance considerations, remains one of the highest-converting Meta tactics for healthcare. Patients who visited a service page and did not convert can be reached again through compliant retargeting.
Promotion of events, webinars, and content downloads tends to perform well within the current restrictions, because the offer is informational rather than directly clinical and the targeting can rely on first-party signals rather than health-inferred interests.
What This Means for Strategy
Practices using Meta as a primary acquisition channel should be running campaigns designed for the current restriction environment, not for the environment that existed when many playbooks were written.
This means investing in first-party audience building over inferred-interest targeting. It means creative that builds awareness and trust rather than creative that promises specific outcomes. It means a Meta strategy positioned alongside Google Ads, organic search, and direct outreach rather than as a standalone solution.
Agencies still selling Meta as a primary direct-response channel for healthcare based on tactics that worked in 2020 are working from an obsolete playbook. The platform still produces results, but the results come from approaches calibrated to current realities, not historical ones.
